McMullin, M. F., Harrison, C. N., Niederwieser, D., Demuynck, H., Jäkel, N., Gopalakrishna, P., . . . Al-Ali, H. (2015). The use of erythropoiesis-stimulating agents with ruxolitinib in patients with myelofibrosis in COMFORT-II: An open-label, phase 3 study assessing efficacy and safety of ruxolitinib versus best available therapy in the treatment of myelofibrosis. Exp Hematol Oncol.
Chicago Stili AlıntıMcMullin, Mary Frances, et al. "The Use of Erythropoiesis-stimulating Agents With Ruxolitinib in Patients With Myelofibrosis in COMFORT-II: An Open-label, Phase 3 Study Assessing Efficacy and Safety of Ruxolitinib Versus Best Available Therapy in the Treatment of Myelofibrosis." Exp Hematol Oncol 2015.
MLA AlıntıMcMullin, Mary Frances, et al. "The Use of Erythropoiesis-stimulating Agents With Ruxolitinib in Patients With Myelofibrosis in COMFORT-II: An Open-label, Phase 3 Study Assessing Efficacy and Safety of Ruxolitinib Versus Best Available Therapy in the Treatment of Myelofibrosis." Exp Hematol Oncol 2015.